Cipla Health's Omnigel debuts first sub-brand Maxstrong in 2% diclofenac category
Omnigel launches Omnigel Maxstrong, entering the higher-strength 2% diclofenac pain-relief segment with a '5X Action' claim, premium packaging, and both gel and spray formats across sizes from 30gm to 100gm.
Cipla Health's pain relief brand Omnigel launches Omnigel Maxstrong, its first sub-brand, entering the 2% diclofenac category with new premium packaging and gel and spray formats across multiple sizes.